SCHEMBL25279274

SCHEMBL25279274

Cc1cccc(C)c1-c1cc(=O)oc2nc(N(C)CC(=O)O)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.34
▸ HPGD P15428 4/20 0.34
▸ CASP1 P29466 3/20 0.34
▸ CASP7 P55210 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MYC P01106 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ EGFR P00533 2/20 0.33
▸ FFAR1 O14842 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ GLA P06280 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ RXRA P19793 1/20 0.33
▸ PSMD14 O00487 1/20 0.32
▸ MMP2 P08253 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25275933 0.91 KCNA3 (0.35) KCNA3ALDH1A1HPGDHSD17B10MYC
SCHEMBL25229541 0.89 KCNA3 (0.42) KCNA3ALDH1A1HPGDCASP1CASP7
SCHEMBL25280965 0.89 ALDH1A1 (0.34) KCNA3ALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL25276303 0.83 KCNA3 (0.38) KCNA3ALDH1A1HPGDMYCKDM4E
SCHEMBL25276304 0.83 KCNA3 (0.38) KCNA3ALDH1A1HPGDMYCKDM4E
SCHEMBL25281739 0.82 KCNA3 (0.39) KCNA3ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL30440359 0.80 KCNA3 (0.35) KCNA3ALDH1A1HPGDHSD17B10MYC
SCHEMBL25272915 0.80 KCNA3 (0.35) KCNA3ALDH1A1HPGDHSD17B10MYC
SCHEMBL25274716 0.79 KCNA3 (0.41) KCNA3ALDH1A1HPGDCASP1CASP7
SCHEMBL25227266 0.78 KCNA3 (0.38) KCNA3ALDH1A1HPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066377-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-02-27 — — US disclosed
WO-2023114539-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-06-22 — — WO disclosed
WO-2023114539-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066377-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT POLRMT, TFAM, POLM KCNA3 4324/4885ALDH1A1 3192/4885HPGD 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback